Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Growing disease awareness initiatives
3.2.1.2 Technological advancements in dermatology and oncology
3.2.1.3 Rising prevalence of BCC
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost associated with treatment
3.2.2.2 Adverse effects
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Pipeline analysis
3.6 Future market trends
3.7 Porter's analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Treatment Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Surgery
5.2.1 By type
5.2.1.1 Electrodessication and curettage
5.2.1.2 Standard surgical excision
5.2.1.3 Mohs surgery
5.2.1.4 Other surgery types
5.2.2 By treatment providers
5.2.2.1 Hospitals
5.2.2.2 Dermatology clinics
5.2.2.3 Cancer treatment centers
5.2.2.4 Other treatment providers
5.3 Medications
5.3.1 By route of administration
5.3.1.1 Topical chemotherapy
5.3.1.2 Oral medications
5.3.2 By distribution channel
5.3.2.1 Hospital pharmacies
5.3.2.2 Retail pharmacies
5.3.2.3 Online pharmacies
5.4 Other treatment types
Chapter 6 Market Estimates and Forecast, By Cancer Type, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Nodular
6.3 Superficial spreading
6.4 Sclerosing
6.5 Pigmented
Chapter 7 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 France
7.3.4 Spain
7.3.5 Italy
7.3.6 The Netherlands
7.3.7 Rest of Europe
7.4 Asia Pacific
7.4.1 China
7.4.2 Japan
7.4.3 India
7.4.4 Australia
7.4.5 South Korea
7.4.6 Rest of Asia Pacific
7.5 Latin America
7.5.1 Brazil
7.5.2 Mexico
7.5.3 Rest of Latin America
7.6 Middle East and Africa
7.6.1 South Africa
7.6.2 Saudi Arabia
7.6.3 UAE
7.6.4 Rest of Middle East and Africa
Chapter 8 Company Profiles
8.1 Service provider
8.1.1 Cleveland Clinic
8.1.2 Dana-Farber Cancer Institute, Inc
8.1.3 Medical Tours
8.1.4 The Johns Hopkins University
8.1.5 The Ohio State University
8.2 Medication manufacturer
8.2.1 Almirall, S.A
8.2.2 Bausch Health Companies Inc.
8.2.3 Dr. Reddy’s Laboratories Ltd.
8.2.4 F. Hoffmann-La Roche Ltd.
8.2.5 Genentech, Inc.
8.2.6 Merck & Co., Inc.
8.2.7 Mylan N.V.
8.2.8 Novartis AG
8.2.9 Sanofi
8.2.10 Sun Pharmaceutical Industries Ltd.
